Your browser doesn't support javascript.
loading
Clinical trial to assess immunogenicity of high-dose, adjuvanted, and recombinant influenza vaccines against cell-grown A(H3N2) viruses in adults 65 to 74 years, 2017-2018.
Belongia, Edward A; Levine, Min Z; Olaiya, Oluwatosin; Gross, F Liaini; King, Jennifer P; Flannery, Brendan; McLean, Huong Q.
Afiliação
  • Belongia EA; Center for Clinical Epidemiology & Population Health, Marshfield Clinic Research Institute, Marshfield, WI, United States. Electronic address: belongia.edward@marshfieldclinic.org.
  • Levine MZ; Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Olaiya O; Center for Clinical Epidemiology & Population Health, Marshfield Clinic Research Institute, Marshfield, WI, United States.
  • Gross FL; Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • King JP; Center for Clinical Epidemiology & Population Health, Marshfield Clinic Research Institute, Marshfield, WI, United States.
  • Flannery B; Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • McLean HQ; Center for Clinical Epidemiology & Population Health, Marshfield Clinic Research Institute, Marshfield, WI, United States.
Vaccine ; 38(15): 3121-3128, 2020 03 30.
Article em En | MEDLINE | ID: mdl-32145994

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana / Imunogenicidade da Vacina Tipo de estudo: Clinical_trials Limite: Aged / Humans Idioma: En Revista: Vaccine Ano de publicação: 2020 Tipo de documento: Article País de publicação: Holanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana / Imunogenicidade da Vacina Tipo de estudo: Clinical_trials Limite: Aged / Humans Idioma: En Revista: Vaccine Ano de publicação: 2020 Tipo de documento: Article País de publicação: Holanda